Riccardin C derivatives as anti-MRSA agents: Structure-activity relationship of a series of hydroxylated bis(bibenzyl)s

Bioorganic and Medicinal Chemistry Letters

Volumn 22, Issue 24, 2012, Pages 7444-7447

  Sawada, Hiromi ^a   Okazaki, Miki ^a   Morita, Daichi ^a   Kuroda, Teruo ^a   Matsuno, Kenji ^a   Hashimoto, Yuichi ^b   Miyachi, Hiroyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti MRSA; Bis(bibenzyl); Riccardin; SAR

Indexed keywords

ANTIINFECTIVE AGENT; HYDROXYL GROUP; RICCARDIN C DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHERS, CYCLIC; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84870239434     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.10.052     Document Type: Article

References (24)

1. Center for Disease Control and Prevention, Public Health Dispatch. Vancomycin-resistant Staphylococcus aureus-Pennsylvania. Morbidity Mortality Weekly Report 2002, 51, 902.
2. C.A. Loffler, and C. MacDougall Expert Rev. Anti Infect. Ther. 5 2007 961
3. M.O. Mitchell Anti Infect. Agents Med. Chem. 6 2007 243
4. C.A. Arias, and B.E.N. Murray Engl. J. Med. 360 2009 439
5. B.S. Speer, N.B. Shoemaker, and A.A. Salyers Clin. Microbiol. Rev. 5 1992 387
6. H.-A. Elsner, W. Kruger, R. Laufs, and D. Mack Eur. J. Clin. Microbiol. Infect. Dis. 16 1997 620
7. R.Y. Hachem, K. Hicks, A. Huen, and I. Raad Clin. Infect. Dis. 37 2003 e8
8. M. Baysallar, A. Kilic, H. Aydogan, F. Cilli, and L. Doganci Int. J. Antimicrob. Agents 23 2004 510
9. S. Navon-Venezia, A. Leavitt, and Y. Carmeli J. Antimicrob. Chemother. 60 2007 449
10. A.I. Hidron, A.N. Schuetz, F.S. Nolte, C.V. Gould, and M.K. Osborn J. Antimicrob. Chemother. 61 2008 1394
11. A.M. Hossion, N. Otsuka, R.K. Kandahary, T. Tsuchiya, W. Ogawa, A. Iwado, Y. Zamami, and K. Sasaki Bioorg. Med. Chem. Lett. 20 2010 5349
12. A.M. Hossion, Y. Zamami, R.K. Kandahary, T. Tsuchiya, W. Ogawa, A. Iwado, and K. Sasaki J. Med. Chem. 54 2011 3686
13. S. Shiota, M. Shimizu, T. Mizushima, H. Ito, T. Hatano, T. Yoshida, and T. Tsuchiya Biol. Pharm. Bull. 22 1999 1388
14. Y. Asakawa, M. Toyota, M. Tori, and T. Hashimoto Spectroscopy 14 2000 149
15. Y. Asakawa, and R. Matsuda Phytochemistry 21 1982 2143
16. T. Yoshida, T. Hashimoto, S. Takaoka, Y. Kan, M. Tori, and Y. Asakawa Tetrahedron 52 1996 14487
17. H. Hioki, N. Shima, K. Kawaguchi, K. Harada, M. Kubo, T. Esumi, T. Nishimaki-Mogami, J.I. Sawada, T. Hashimoto, Y. Asakawa, and Y. Fukuyama Bioorg. Med. Chem. Lett. 19 2009 738
18. N. Tamehiro, Y. Sato, T. Suzuki, T. Hashimoto, Y. Asakawa, S. Yokoyama, T. Kawanishi, Y. Ohno, K. Inoue, T. Nagao, and T. Nishimaki-Mogami FEBS Lett. 579 2005 5299
19. A.-H. Xu, Z.-M. Hu, J.B. Qu, S.M. Liu, A.K.A. Syed, H.-Q. Yuan, and H.-X. Lou Acta Pharmacol. Sin. 31 2010 609
20. L. Harinantenaina, and Y. Asakawa Nat. Prod. Commun. 2 2007 701
21. K. Dodo, A. Aoyama, T. Noguchi-Yachide, M. Makishima, H. Miyachi, and Y. Hashimoto Bioorg. Med. Chem. 16 2008 4272
22. 2-Phenoxyphenol: M. Pettersson, B.M. Campbell, A.B. Dounay, D.L. Gray, L. Xie, C.J. O'Donnell, N.C. Stratman, K. Zoski, E. Drummond, G. Bora, A. Probert, and T. Whisman Bioorg. Med. Chem. Lett. 21 2011 865
23. (1,1′-Biphenyl)-2,4′-diol: M.T. Rubino, D. Maggi, A. Laghezza, F. Loiodice, and P. Tortorella Arch. Pharm. (Weinheim) 344 2011 557
24. 3-[2-(4-Hydroxyphenyl)ethyl]phenol: V. Roldos, H. Nakayama, M. Rolón, A. Montero-Torres, F. Trucco, S. Torres, C. Vega, Y. Marrero-Ponce, V. Heguaburu, G. Yaluff, A. Gómez-Barrio, L. Sanabria, M.E. Ferreira, D. Rojas, A. Arias, and E. Pandolfi Eur. J. Med. Chem. 43 2008 1797